09 Aug 20:34
by Matic Proj
Bioconjug Chem. 2023 Jul 19;34(7):1271-1281. doi: 10.1021/acs.bioconjchem.3c00163. Epub 2023 Jun 24.
ABSTRACT
The binucleophilic properties of 1,2-aminothiol and its rare occurrence in nature make it a useful reporter for tracking molecules in living systems. The 1,2-aminothiol moiety is present in cysteine, which is a substrate for a biocompatible click reaction with heteroaromatic nitriles. Despite the wide range of applications for this reaction, the scope of nitrile substrates has been explored only to a limited extent. In this study, we expand the chemical space of heteroaromatic nitriles for bioconjugation under physiologically relevant conditions. We systematically assembled a library of 116 2-cyanobenzimidazoles, 1-methyl-2-cyanobenzimidazoles, 2-cyanobenzothiazoles, and 2-cyanobenzoxazoles containing electron-donating and electron-withdrawing substituents at all positions of the benzene ring. The compounds were evaluated for their stability, reactivity, and selectivity toward the N-terminal cysteine of model oligopeptides. In comparison to the benchmark 6-hydroxy-2-cyanobenzothiazole or 6-amino-2-cyanobenzothiazole, we provide highly selective and moderately reactive nitriles as well as highly reactive yet less selective analogs with a variety of enabling attachment chemistries to aid future applications in bioconjugation, chemical biology, and nanomaterial science.
PMID:37354098 | PMC:PMC10360065 | DOI:10.1021/acs.bioconjchem.3c00163
10 Jul 20:12
by Stefano Gambato, Ottavia Bellotto, Mario Mardirossian, Adriana Di Stasi, Renato Gennaro, Sabrina Pacor, Andrea Caporale, Federico Berti, Marco Scocchi, and Alessandro Tossi

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.2c00467
10 Jul 20:10
by Jesse M. McFarland, Maša Alečković, George Coricor, Sangeetha Srinivasan, Matthew Tso, John Lee, Tri-Hung Nguyen, and José M. Mejía Oneto

ACS Central Science
DOI: 10.1021/acscentsci.3c00365
30 Jun 19:03
by Csaba Bató
Pharmaceutics. 2023 Jun 14;15(6):1736. doi: 10.3390/pharmaceutics15061736.
ABSTRACT
Delivering therapeutic agents into cells has always been a major challenge. In recent years, cyclization emerged as a tool for designing CPPs to increase their internalization and stability. Cyclic ring(s) can protect the peptide from enzymatic degradation, so cyclic peptides remain intact. Therefore they can be good carrier molecules. In this work, the preparation and investigation of efficient cyclic CPPs are described. Different oligoarginines were designed to conjugate with rigid aromatic scaffolds or form disulfide bonds. The reaction between the scaffolds and the peptides forms stable thioether bonds, constraining the peptide into a cyclic structure. The constructs presented very efficient internalization on cancerous cell lines. Our peptides use more than one endocytic pathway for cellular uptake. In this way, short peptides, which can compete with the penetration of well-known CPPs such as octaarginine (Arg8), may be synthesized through cyclization.
PMID:37376184 | PMC:PMC10302231 | DOI:10.3390/pharmaceutics15061736
30 Jun 18:50
by Jack Arnold,
Joshua Glazier,
Mark Mimee
aPritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, USA
bDepartment of Microbiology, University of Chicago, Chicago, Illinois, USA
Journal of Bacteriology,
Volume 205, Issue 7, July 2023.
30 Jun 18:50
by Stefano Gambato, Ottavia Bellotto, Mario Mardirossian, Adriana Di Stasi, Renato Gennaro, Sabrina Pacor, Andrea Caporale, Federico Berti, Marco Scocchi, and Alessandro Tossi

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.2c00467
26 Jun 20:16
by Matic Proj, Nika Strašek, Stane Pajk, Damijan Knez, and Izidor Sosič

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.3c00163
26 Jun 20:13
by Kristine L. Trotta
by Kristine L. Trotta, Beth M. Hayes, Johannes P. Schneider, Jing Wang, Horia Todor, Patrick Rockefeller Grimes, Ziyi Zhao, William L. Hatleberg, Melanie R. Silvis, Rachel Kim, Byoung Mo Koo, Marek Basler, Seemay Chou
Gram-negative bacteria can antagonize neighboring microbes using a type VI secretion system (T6SS) to deliver toxins that target different essential cellular features. Despite the conserved nature of these targets, T6SS potency can vary across recipient species. To understand the functional basis of intrinsic T6SS susceptibility, we screened for essential
Escherichia coli (Eco) genes that affect its survival when antagonized by a cell wall-degrading T6SS toxin from
Pseudomonas aeruginosa, Tae1. We revealed genes associated with both the cell wall and a separate layer of the cell envelope, lipopolysaccharide, that modulate Tae1 toxicity
in vivo. Disruption of genes in early lipopolysaccharide biosynthesis provided
Eco with novel resistance to Tae1, despite significant cell wall degradation. These data suggest that Tae1 toxicity is determined not only by direct substrate damage, but also by indirect cell envelope homeostasis activities. We also found that Tae1-resistant
Eco exhibited reduced cell wall synthesis and overall slowed growth, suggesting that reactive cell envelope maintenance pathways could promote, not prevent, self-lysis. Together, our study reveals the complex functional underpinnings of susceptibility to Tae1 and T6SS which regulate the impact of toxin-substrate interactions
in vivo.
26 Jun 19:01
by Vanitha Selvarajan, Nhan D. T. Tram, Jian Xu, Sarah T. Y. Ngen, Jun-Jie Koh, Jeanette W. P. Teo, Tsz-Ying Yuen, and Pui Lai Rachel Ee

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c00140
23 Jun 14:01
by Arianna Mayorga-Ramos, Johana Zúñiga-Miranda, Saskya E. Carrera-Pacheco, Carlos Barba-Ostria, and Linda P. Guamán

ACS Infectious Diseases
DOI: 10.1021/acsinfecdis.2c00649
23 Jun 14:00
by Marta Selma-Royo
Nature Biotechnology, Published online: 22 June 2023; doi:10.1038/s41587-023-01852-2
An automated system for picking bacterial colonies is used to create a biobank of personalized microbiomes.
22 Jun 13:40
by Jessica R McCann
Annu Rev Microbiol. 2023 Jun 20. doi: 10.1146/annurev-micro-032421-111819. Online ahead of print.
ABSTRACT
Amino acids are indispensable substrates for protein synthesis in all organisms and incorporated into diverse aspects of metabolic physiology and signaling. However, animals lack the ability to synthesize several of them and must acquire these essential amino acids from their diet or perhaps their associated microbial communities. The essential amino acids therefore occupy a unique position in the health of animals and their relationships with microbes. Here we review recent work connecting microbial production and metabolism of essential amino acids to host biology, and the reciprocal impacts of host metabolism of essential amino acids on their associated microbes. We focus on the roles of the branched-chain amino acids (valine, leucine, and isoleucine) and tryptophan on host-microbe communication in the intestine of humans and other vertebrates. We then conclude by highlighting research questions surrounding the less-understood aspects of microbial essential amino acid synthesis in animal hosts. Expected final online publication date for the Annual Review of Microbiology, Volume 77 is September 2023. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
PMID:37339735 | DOI:10.1146/annurev-micro-032421-111819
21 Jun 21:52
by Minsang Kim
Adv Sci (Weinh). 2023 Jun 21:e2302483. doi: 10.1002/advs.202302483. Online ahead of print.
ABSTRACT
Antimicrobial peptides (AMPs) are promising therapeutics in the fight against multidrug-resistant bacteria. As a mimic of AMPs, peptoids with N-substituted glycine backbone have been utilized for antimicrobials with resistance against proteolytic degradation. Antimicrobial peptoids are known to kill bacteria by membrane disruption; however, the nonspecific aggregation of intracellular contents is also suggested as an important bactericidal mechanism. Here,structure-activity relationship (SAR) of a library of indole side chain-containing peptoids resulting in peptoid 29 as a hit compound is investigated. Then, quantitative morphological analyses of live bacteria treated with AMPs and peptoid 29 in a label-free manner using optical diffraction tomography (ODT) are performed. It is unambiguously demonstrated that both membrane disruption and intracellular biomass flocculation are primary mechanisms of bacterial killing by monitoring real-time morphological changes of bacteria. These multitarget mechanisms and rapid action can be a merit for the discovery of a resistance-breaking novel antibiotic drug.
PMID:37341246 | DOI:10.1002/advs.202302483
21 Jun 21:52
by Takayuki Katoh
Nucleic Acids Res. 2023 Aug 25;51(15):8169-8180. doi: 10.1093/nar/gkad496.
ABSTRACT
Translation initiation using noncanonical initiator substrates with poor peptidyl donor activities, such as N-acetyl-l-proline (AcPro), induces the N-terminal drop-off-reinitiation event. Thereby, the initiator tRNA drops-off from the ribosome and the translation reinitiates from the second amino acid to yield a truncated peptide lacking the N-terminal initiator substrate. In order to suppress this event for the synthesis of full-length peptides, here we have devised a chimeric initiator tRNA, referred to as tRNAiniP, whose D-arm comprises a recognition motif for EF-P, an elongation factor that accelerates peptide bond formation. We have shown that the use of tRNAiniP and EF-P enhances the incorporation of not only AcPro but also d-amino, β-amino and γ-amino acids at the N-terminus. By optimizing the translation conditions, e.g. concentrations of translation factors, codon sequence and Shine-Dalgarno sequence, we could achieve complete suppression of the N-terminal drop-off-reinitiation for the exotic amino acids and enhance the expression level of full-length peptide up to 1000-fold compared with the use of the ordinary translation conditions.
PMID:37334856 | PMC:PMC10450175 | DOI:10.1093/nar/gkad496
21 Jun 21:51
by Cunyuan Zhao, Yuankai Wang, Quan Pham, Changhang Dai, Abhishek Chatterjee, and Masayuki Wasa

Journal of the American Chemical Society
DOI: 10.1021/jacs.3c00169
19 Jun 16:03
by Pranab Chandra Saha, Rabi Sankar Das, Shreya Das, Nayim Sepay, Tanima Chatterjee, Ayan Mukherjee, Tapas Bera, Samiran Kar, Maitree Bhattacharyya, Arunima Sengupta, and Samit Guha

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.3c00185
19 Jun 16:03
by Vasilisa V. Krasitskaya, Maxim K. Efremov, and Ludmila A. Frank

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.3c00165
19 Jun 16:01
by Bailey J Schultz
Nat Microbiol. 2023 Jul;8(7):1318-1329. doi: 10.1038/s41564-023-01411-0. Epub 2023 Jun 12.
ABSTRACT
Bacterial cell envelope polymers are often modified with acyl esters that modulate physiology, enhance pathogenesis and provide antibiotic resistance. Here, using the D-alanylation of lipoteichoic acid (Dlt) pathway as a paradigm, we have identified a widespread strategy for how acylation of cell envelope polymers occurs. In this strategy, a membrane-bound O-acyltransferase (MBOAT) protein transfers an acyl group from an intracellular thioester onto the tyrosine of an extracytoplasmic C-terminal hexapeptide motif. This motif shuttles the acyl group to a serine on a separate transferase that moves the cargo to its destination. In the Dlt pathway, here studied in Staphylococcus aureus and Streptococcus thermophilus, the C-terminal 'acyl shuttle' motif that forms the crucial pathway intermediate is found on a transmembrane microprotein that holds the MBOAT protein and the other transferase together in a complex. In other systems, found in both Gram-negative and Gram-positive bacteria as well as some archaea, the motif is fused to the MBOAT protein, which interacts directly with the other transferase. The conserved chemistry uncovered here is widely used for acylation throughout the prokaryotic world.
PMID:37308592 | PMC:PMC10664464 | DOI:10.1038/s41564-023-01411-0
19 Jun 16:00
by Lepeng Zhou
Cell Host Microbe. 2023 Jun 7:S1931-3128(23)00215-9. doi: 10.1016/j.chom.2023.05.022. Online ahead of print.
ABSTRACT
The microbiomes of cesarean-born infants differ from vaginally delivered infants and are associated with increased disease risks. Vaginal microbiota transfer (VMT) to newborns may reverse C-section-related microbiome disturbances. Here, we evaluated the effect of VMT by exposing newborns to maternal vaginal fluids and assessing neurodevelopment, as well as the fecal microbiota and metabolome. Sixty-eight cesarean-delivered infants were randomly assigned a VMT or saline gauze intervention immediately after delivery in a triple-blind manner (ChiCTR2000031326). Adverse events were not significantly different between the two groups. Infant neurodevelopment, as measured by the Ages and Stages Questionnaire (ASQ-3) score at 6 months, was significantly higher with VMT than saline. VMT significantly accelerated gut microbiota maturation and regulated levels of certain fecal metabolites and metabolic functions, including carbohydrate, energy, and amino acid metabolisms, within 42 days after birth. Overall, VMT is likely safe and may partially normalize neurodevelopment and the fecal microbiome in cesarean-delivered infants.
PMID:37327780 | DOI:10.1016/j.chom.2023.05.022
19 Jun 16:00
by Peng Yang
J Am Chem Soc. 2023 Jun 16. doi: 10.1021/jacs.3c03512. Online ahead of print.
ABSTRACT
The three-dimensional structure of medium-sized cyclic peptides accounts for their biological activity and other important physiochemical properties. Despite significant advances in the past few decades, chemists' ability to fine-tune the structure, in particular, the backbone conformation, of short peptides made of canonical amino acids is still quite limited. Nature has shown that cross-linking the aromatic side chains of linear peptide precursors via enzyme catalysis can generate cyclophane-braced products with unusual structures and diverse activities. However, the biosynthetic path to these natural products is challenging to replicate in the synthetic laboratory using practical chemical modifications of peptides. Herein, we report a broadly applicable strategy to remodel the structure of homodetic peptides by cross-linking the aromatic side chains of Trp, His, and Tyr residues with various aryl linkers. The aryl linkers can be easily installed via copper-catalyzed double heteroatom-arylation reactions of peptides with aryl diiodides. These aromatic side chains and aryl linkers can be combined to form a large variety of assemblies of heteroatom-linked multi-aryl units. The assemblies can serve as tension-bearable multijoint braces to modulate the backbone conformation of peptides as an entry to previously inaccessible conformational space.
PMID:37326500 | DOI:10.1021/jacs.3c03512
19 Jun 15:59
by Yuka Ikeda
Molecules. 2023 May 28;28(11):4392. doi: 10.3390/molecules28114392.
ABSTRACT
Microbiome dysbiosis resulting in altered metabolite profiles may be associated with certain diseases, including inflammatory bowel diseases (IBD), which are characterized by active intestinal inflammation. Several studies have indicated the beneficial anti-inflammatory effect of metabolites from gut microbiota, such as short-chain fatty acids (SCFAs) and/or D-amino acids in IBD therapy, through orally administered dietary supplements. In the present study, the potential gut protective effects of d-methionine (D-Met) and/or butyric acid (BA) have been investigated in an IBD mouse model. We have also built an IBD mouse model, which was cost-effectively induced with low molecular weight DSS and kappa-carrageenan. Our findings revealed that D-Met and/or BA supplementation resulted in the attenuation of the disease condition as well as the suppression of several inflammation-related gene expressions in the IBD mouse model. The data shown here may suggest a promising therapeutic potential for improving symptoms of gut inflammation with an impact on IBD therapy. However, molecular metabolisms need to be further explored.
PMID:37298868 | PMC:PMC10254188 | DOI:10.3390/molecules28114392
19 Jun 15:58
by Abhishek Saha
Acc Chem Res. 2023 Jul 18;56(14):1953-1965. doi: 10.1021/acs.accounts.3c00178. Epub 2023 Jun 13.
ABSTRACT
Chemical manipulation of naturally occurring peptides offers a convenient route for generating analogs to screen against different therapeutic targets. However, the limited success of the conventional chemical libraries has urged chemical biologists to adopt alternative methods such as phage and mRNA displays and create libraries of a large number of variants for the screening and selection of novel peptides. Messenger RNA (mRNA) display provides great advantages in terms of the library size and the straightforward recovery of the selected polypeptide sequences. Importantly, the integration of the flexible in vitro translation (FIT) system with the mRNA display provides the basis of the random nonstandard peptides integrated discovery (RaPID) approach for the introduction of diverse nonstandard motifs, such as unnatural side chains and backbone modifications. This platform allows the discovery of functionalized peptides with tight binding against virtually any protein of interest (POI) and therefore shows great potential in the pharmaceutical industry. However, this method has been limited to targets generated by recombinant expression, excluding its applications to uniquely modified proteins, particularly those with post-translational modifications.Chemical protein synthesis allows a wide range of changes to the protein's chemical composition to be performed, including side chain and backbone modifications and access to post-translationally modified proteins, which are often inaccessible or difficult to achieve via recombinant expression methods. Notably, d-proteins can be prepared via chemical synthesis, which has been used in mirror image phase display for the discovery of nonproteolytic d-peptide binders.Combining chemical protein synthesis with the RaPID system allows the production of a library of trillions of cyclic peptides and subsequent selection for novel cyclic peptide binders targeting a uniquely modified protein to assist in studying its unexplored biology and possibly the discovery of new drug candidates.Interestingly, the small post-translational modifier protein ubiquitin (Ub), with its various polymeric forms, regulates directly or indirectly many biochemical processes, e.g., proteasomal degradation, DNA damage repair, cell cycle regulation, etc. In this Account, we discuss combining the RaPID approach against various synthetic Ub chains for selecting effective and specific macrocyclic peptide binders. This offers an advancement in modulating central Ub pathways and provides opportunities in drug discovery areas associated with Ub signaling. We highlight experimental approaches and conceptual adaptations required to design and modulate the activity of Lys48- and Lys63-linked Ub chains by macrocyclic peptides. We also present the applications of these approaches to shed light on related biological activities and ultimately their activity against cancer. Finally, we contemplate future developments still pending in this exciting multidisciplinary field.
PMID:37312234 | PMC:PMC10357587 | DOI:10.1021/acs.accounts.3c00178
19 Jun 15:57
by Lars Hellweg
Nature Chemical Biology, Published online: 08 June 2023; doi:10.1038/s41589-023-01350-1
Fluorescent proteins and HaloTag allow the flexible design of FRET-based biosensors with adjustable color using different fluorescent proteins or fluorophores and readout can be modified to fluorescence intensity, lifetime or bioluminescence.
19 Jun 15:57
by Priscilla Dzigba, Adrian K. Rylski, Isaac J. Angera, Nicholas Banahene, Herbert W. Kavunja, Mallary C. Greenlee-Wacker, and Benjamin M. Swarts

ACS Chemical Biology
DOI: 10.1021/acschembio.3c00155
19 Jun 15:57
by Kristie E. Darrah, Savannah Albright, Rohan Kumbhare, Michael Tsang, James K. Chen, and Alexander Deiters

ACS Chemical Biology
DOI: 10.1021/acschembio.3c00027
19 Jun 15:55
by Kalinka Koteva, Min Xu, Wenliang Wang, Aline A. Fiebig-Comyn, Michael A. Cook, Brian K. Coombes, and Gerard D. Wright

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c00633
19 Jun 15:55
by Chuanjie Chen, Yiwen Yang, Zhe Wang, Huiwen Li, Chanjuan Dong, and Xuan Zhang

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c00302
19 Jun 15:55
by Gangqiang Yang, Shuqi Liu, Chen Zhang, Liping Yu, Zongji Zou, Conghui Wang, Meng Gao, Shuang Li, Yiqi Ma, Ruoxuan Xu, Zhihua Song, Rongxia Liu, and Hongbo Wang

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c00283
09 Jun 17:55
by Jiantao Hu, Biao Hu, Fuming Xu, Mi Wang, Chong Qin, Donna McEachern, Jeanne Stuckey, and Shaomeng Wang

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c00520
09 Jun 17:55
by Derek C. K. Chan, Katherine Dykema, Mahrukh Fatima, Hanjeong Harvey, Ikram Qaderi, and Lori L. Burrows

ACS Infectious Diseases
DOI: 10.1021/acsinfecdis.3c00167